YOLFTbeta
Adheris Health Limited

Adheris Health Limited

AHE · AU · Healthcare / Health Information Services

0.013AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.013
Open0.013
Day Range0.012 – 0.013
52-Week Range0.011 – 0.042
Volume589.21K
Market Cap8.29M
P/E (TTM)0.00
Forward P/E8.00
EPS-0.03
Dividend Yield0.00%
Beta1.06
50-Day Avg0.0147
200-Day Avg0.0181

About

Adheris Health Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in the United States. The company offers THRiV, a patient engagement platform, which transforms the patient experience by harnessing predictive modeling and precision segmentation. The company was formerly known as MedAdvisor Limited and changed its anme to Adheris Health Limited in November 2025. The company was incorporated in 2010 and is based in Woburn, Massachusetts.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. John Ciccio
  • Headquarters100 TradeCenter, Woburn, MA, United States, 01801, Australia
  • Websitehttps://www.medadvisorsolutions.com

Leadership

  • Mr. John CiccioCEO, MD & Director · b. 1981
  • Mr. Sean SlatteryCompany Secretary
  • Ms. Alison HaleChief Financial Officer
  • Mr. Craig SchnurigerChief Technology Officer
  • Mr. James M. Rotsart R.Ph.Executive VP of US & Client Relations
  • Mr. Brian PetersonPresident of US
  • Mr. Lee TamplinCompany Secretary

Financials

Income Statement

Currency: AUD2011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue--857.14K1.07M1.65M1.43M4.24M6.60M8.24M9.60M38.77M67.75M97.96M122.11M62.99M33.96M
Growth (%)---+24.28%+54.49%-13.36%+197.57%+55.67%+24.79%+16.51%+303.77%+74.74%+44.60%+24.64%-48.41%-46.09%
Cost of Revenue-288.10K1.03M1.43M1.79M2.92M3.84M6.06M10.03M13.23M44.83M69.59M85.38M98.47M59.02M37.45M
Gross Profit--288.10K-168.40K-362.84K-144.29K-1.49M402.53K549.01K-1.78M-3.63M-6.06M-1.84M12.59M23.63M3.97M-3.49M
Gross Margin---19.65%-34.06%-8.77%-104.80%9.49%8.31%-21.65%-37.82%-15.62%-2.72%12.85%19.35%6.31%-10.27%
Operating Expense-825.02K3.48M10.80M523.26K1.42M3.86M5.15M6.44M7.50M12.26M14.35M20.30M20.93M10.71M13.18M
Operating Income-94.51K-1.11M-3.65M-11.16M-667.55K-2.92M-3.45M-4.60M-8.22M-11.13M-18.31M-16.19M-7.72M2.70M-6.73M-16.67M
Operating Margin---425.57%-1047.83%-40.56%-204.49%-81.39%-69.61%-99.73%-115.93%-47.23%-23.89%-7.88%2.21%-10.69%-49.09%
EBITDA-70.23K-993.26K-3.75M-11.14M-666.01K-2.88M-3.40M-4.24M-7.83M-10.34M-14.93M-11.29M-3.03M7.05M-11.93M-16.53M
EBITDA Margin---436.98%-1045.74%-40.47%-202.12%-80.25%-64.27%-94.95%-107.68%-38.49%-16.66%-3.09%5.77%-18.94%-48.66%
Net Income-70.23K-993.41K-3.75M-11.14M-666.97K-3.07M-3.43M-4.45M-8.10M-9.58M-13.95M-17.35M-11.31M792.13K-60.21M-19.97M
Net Income Margin---437.15%-1046.14%-40.53%-215.39%-80.84%-67.44%-98.29%-99.82%-35.98%-25.60%-11.54%0.65%-95.58%-58.80%
R&D--1.03M820.64K150.15K231.06K1.81M3.66M7.38M2.50M4.81M6.15M7.51M---
R&D as % of Total Revenue--119.65%77.04%9.12%16.21%42.65%55.44%89.54%26.08%12.41%9.08%7.66%---
Interest Expense---16.61K2.85K210.98K73.06K11.96K16.31K115.10K422.09K1.54M2.13M1.93M2.87M3.70M
Interest Expense % of Total Revenue---1.56%0.17%14.80%1.72%0.18%0.20%1.20%1.09%2.28%2.18%1.58%4.56%10.89%

Balance Sheet

Currency: AUD2011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets3.41M3.29M11.91M705.50K197.70K3.65M11.10M17.38M11.77M21.27M80.92M78.44M95.91M98.78M39.84M16.59M
Total Liabilities268.27K507.83K796.37K394.51K304.58K1.18M1.75M2.21M3.13M4.25M32.07M43.89M47.45M47.20M41.46M19.03M
Total Equity3.14M2.78M11.11M310.98K-106.88K2.46M9.35M15.17M8.64M16.66M48.45M34.55M48.46M51.58M-1.62M-2.44M
Cash3.24M2.56M2.97M308.02K165.03K2.89M4.83M10.47M4.40M12.35M7.15M7.58M14.20M15.58M10.30M9.53M
Total Debt----345.00K----1.42M9.16M13.41M13.09M12.61M17.40M131.74K
Net Debt-3.24M-2.56M-2.97M-308.02K179.97K-2.89M-4.83M-10.47M-4.40M-10.92M2.01M5.84M-1.11M-2.97M7.09M-9.40M

Cash Flow

Currency: AUD2011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-12.62K-577.73K-3.33M-2.50M-477.40K-2.55M-2.40M-3.27M-6.95M-8.68M-12.54M-236.32K-1.45M5.19M-14.37M-10.27M
Investing Cash Flow-39.20K-635.36K-1.13M-271.72K-53.60K-177.15K-3.02M-521.34K-103.89K230.68K-43.36M-290.79K-3.23M-2.80M-2.18M9.92M
Financing Cash Flow3.29M530.25K4.88M101.00K217.05K5.04M7.37M9.43M975.00K16.39M51.24M1.86M12.42M-831.97K11.34M284.23K
Capital Expenditure39.20K388.34K1.13M271.72K53.60K199.29K36.14K405.58K103.89K324.21K392.11K311.81K178.68K1.83M1.09M0
Free Cash Flow-12.62K-966.06K-4.46M-2.77M-531.00K-2.75M-2.44M-3.67M-7.05M-9.00M-12.94M-548.13K-1.63M3.35M-14.37M-10.27M
Dividends Paid-----4.39M6.83M---------
FCF to OCF100.00%167.22%133.87%110.89%111.23%107.83%101.50%112.41%101.50%103.73%103.13%231.95%112.29%64.65%100.00%100.00%
Dividend Paid to FCF------159.72%-279.89%---------

Key Statistics & Ratios

Market Cap8.29M
Enterprise Value-1.74M
Trailing P/E0.00
Forward P/E8.00
Price / Sales0.24
Price / Book0.93
EPS-0.03
Book Value-0.004
Revenue (TTM)33.96M
Gross Profit (TTM)-2.81M
EBITDA-16.11M
Profit Margin-12.69%
Operating Margin-47.58%
Return on Equity-177.91%
Return on Assets-35.79%
Shares Outstanding637.98M
Shares Float360.71M
Beta1.06
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20151×
0.09Mar 12, 2015
20142×
0.13Sep 10, 20140.09Mar 12, 2014
20132×
0.12Sep 10, 20130.08Mar 12, 2013
20122×
0.11Sep 11, 20120.07Mar 13, 2012
20111×
0.10Sep 12, 2011

Stock Splits

  • Nov 19, 20191:7